跳至主要内容
临床试验/NCT00656760
NCT00656760已完成不适用

The Clinical Utility of PET-CT in the Management of Squamous Cell Carcinoma of Neck Nodes With an Unknown Primary Malignancy.

University of Calgary1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2007年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
proportion of patients where PET/CT resulted in a change in diagnosis

研究概览

简要总结

Historically metastatic squamous cell carcinoma in a cervical lymph node from an occult primary malignancy of the head and neck was evaluated with panendoscopy and biopsies of high risk areas, such as the base of tongue, nasopharynx, and tonsils. This diagnostic protocol identifies the primary malignancy in about 50% of cases. In recent years, the availability of CT has slightly increased the detection rate to 65% when used as an adjunct to the traditional work-up. Studies using PET as an adjunct are conflicting with detection rates ranging up to 75%. Currently, no prospective study has analyzed the role of the PET-CT fusion in the work-up of an occult primary malignancy of the head and neck. This study will compare the detection rate of the traditional work-up to a new protocol involving a pre-operative diagnostic PET-CT.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
Single (Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age > 18 years old
  • •Biopsy proven SCC in a cervical lymph node
  • •Unknown primary cancer after: History, Physical exam, and office endoscopy by otolaryngologist
  • •Negative Chest X-Ray for malignancy
  • •Patient consent signed to undergo investigative protocol

排除标准

  • •Un-fit for general anesthesia
  • •Unable to lie flat for 45 minutes
  • •Unable to fast for > 6 hours
  • •Unable to perform PET-CT (Obesity > 150kg)
  • •Prior Head and Neck cancer
  • •Any invasive cancer (Non-Head and Neck) within the last 2 years

研究组 & 干预措施

A

Experimental

All patients have PET/CT and biopsies with the surgeon blinded to the result of PET/CT. Additional biopsies are performed (or not) after the surgeon has the PET/CT results revealed.

干预措施: PET/CT (Other)

结局指标

主要结局

proportion of patients where PET/CT resulted in a change in diagnosis

时间窗: 2 weeks after surgery

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joseph C. Dort

Professor of Surgery

University of Calgary

研究点 (1)

Loading locations...

相似试验

已完成
不适用
PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary MalignancySquamous Cell Cancer
NCT00530283AHS Cancer Control Alberta20
已完成
不适用
Validation of High-resolution PET/CT for the Pretherapeutic Lymphnode Staging of Head/Neck CancerOtorhinolaryngeal NeoplasmsCancer of Head and Neck
NCT02372890Insel Gruppe AG, University Hospital Bern153
已完成
不适用
A Study of Intensity-modulated Radiotherapy in Patients With Squamous Cell Carcinoma of Unknown Primary (SCCUP) of the Head and NeckHead and Neck Cancer
NCT02112344Royal Marsden NHS Foundation Trust19
已完成
不适用
Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic CorrelationHead and Neck CancerCarcinoma, Squamous CellHead and Neck Cancers
NCT00313027Stanford University30
已完成
不适用
PET/MRI for initial staging of squamous cell carcinoma of the head and necksquamous cell carcinoma of the head and neckC00C01C02C03C04C05C06C09C10C11C12C13C14Malignant neoplasm of lipMalignant neoplasm of base of tongueMalignant neoplasm of other and unspecified parts of tongueMalignant neoplasm of gumMalignant neoplasm of floor of mouthMalignant neoplasm of palateMalignant neoplasm of other and unspecified parts of mouthMalignant neoplasm of tonsilMalignant neoplasm of oropharynxMalignant neoplasm of nasopharynxMalignant neoplasm of piriform sinusMalignant neoplasm of hypopharynxMalignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
DRKS00023750niversitätsklinikum Essen, Institut für Diagnostische und Interventionelle Radiologie und Neuroradiologie140